Page last updated: 2024-09-05

tak 779 and bms 806

tak 779 has been researched along with bms 806 in 2 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(bms 806)
Trials
(bms 806)
Recent Studies (post-2010) (bms 806)
11813545018

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)bms 806 (IC50)
Cytochrome P450 2D6Homo sapiens (human)9.7
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 Human immunodeficiency virus 18.7

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CH; Ho, P; Huang, L; Lai, W; Li, Z; Montefiori, D1
Maddon, PJ; Olson, WC1

Reviews

1 review(s) available for tak 779 and bms 806

ArticleYear
Resistance to HIV-1 entry inhibitors.
    Current drug targets. Infectious disorders, 2003, Volume: 3, Issue:4

    Topics: Amides; Anti-HIV Agents; Benzylamines; CD4 Immunoadhesins; Cyclams; Drug Resistance, Viral; Enfuvirtide; Heterocyclic Compounds; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Peptide Fragments; Piperazines; Quaternary Ammonium Compounds

2003

Other Studies

1 other study(ies) available for tak 779 and bms 806

ArticleYear
Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Animals; Anti-HIV Agents; Betulinic Acid; Cell Line; Chlorocebus aethiops; COS Cells; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Membrane Fusion; Microbial Sensitivity Tests; Models, Molecular; Pentacyclic Triterpenes; Peptide Fragments; Triterpenes

2008